EAU 2017 | How can sequential therapy be used in castration-resistant prostate cancer?

Gerald Mickisch

Gerald Mickisch, MD, from the Bremen Center of Operative Urology, Bremen, Germany, discusses how sequential therapy can be used in the treatment of castration-resistant prostate cancer at the European Association of Urology (EAU) conference 2017 in London, UK. Prof. Mickisch explains the efficacy of sequential therapy, and speaks about the order in which treatments are typically given to improve overall survival (OS).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter